Possible Role of Matrix Metalloproteinase in Osteolytic Intracranial Meningiomas.
10.3340/jkns.2010.47.1.11
- Author:
Hyung Sik MOON
1
;
Shin JUNG
;
Tae Young JUNG
;
Van Thang CAO
;
Kyung Sub MOON
;
In Young KIM
Author Information
1. Department of Neurosurgery, Chonnam National University Hwasun Hospital & Medical School, Gwangju, Korea.
- Publication Type:Original Article
- Keywords:
Matrix metalloproteinase;
Meningioma;
Osteolytic
- MeSH:
Gelatin;
Humans;
Hyperostosis;
Meningioma;
Osteolysis;
Polymerase Chain Reaction;
Prognosis;
Skull
- From:Journal of Korean Neurosurgical Society
2010;47(1):11-16
- CountryRepublic of Korea
- Language:English
-
Abstract:
OBJECTIVE: Abnormalities of the bone are frequently encountered in patients with meningioma, and hyperostosis and endostosis are common bone alterations in these tumors. Extensive bony destruction is very unusual in patients with meningioma. We report six cases of intracranial meningioma associated with an osteolytic lesion of the skull and discuss the underlying mechanisms that may be responsible for bone destruction in patients with meningioma. METHODS: Six patients were classified into three groups, severe, moderate and mild, according to the degree of osteolytic bony destruction. The tumor was classified as intracranial or extracranial, depending on its location. We investigated the potential role of matrix metalloproteinase (MMP) in meningioma-associated osteolysis. The levels of MMP expression were determined by gelatin zymography, reverse transcription-quantitative PCR analysis (RT-PCR) and immunohistochemical analysis. RESULTS: Complete surgical removal of the lesion was performed in each patient. Histological examination revealed benign meningioma in four cases, and two cases of atypical meningioma. Patients did not have a poor prognosis except one case of recurred atypical meningioma. Gelatin zymography and RT-PCR detected high levels of MMP-2 in almost all extracranial masses in comparison with the intracranial masses and MMP-9 in two. There was no difference in the severity of bone destruction. Immunohistochemical analysis revealed MMP-2 expression in the vicinity of the bone destruction, and a few MMP-9-positive stainings were observed. CONCLUSION: Osteolysis of the skull in patients with meningiomas might not be indicative of malignant pathological features and poor prognosis. Invasion to the extracranial portion and osteolysis might be associated with MMP-2 expression in meningioma.
